What predicts response to sertraline for people with depression in primary care? A secondary data analysis of moderators in the PANDA trial

Charlotte S Archer*, David S Kessler, Gemma Lewis, Ricardo Araya, Larisa Duffy, Simon Gilbody, Glyn Lewis, Tony Kendrick, TJ Peters, Nicola J Wiles

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

1 Citation (Scopus)
10 Downloads (Pure)

Abstract

Purpose
Antidepressants are a first-line treatment for depression, yet many patients do not respond. There is a need to understand which patients have greater treatment response but there is little research on patient characteristics that moderate the effectiveness of antidepressants. This study examined potential moderators of response to antidepressant treatment.

Methods
The PANDA trial investigated the clinical effectiveness of sertraline (n=326) compared with placebo (n=329) in primary care patients with depressive symptoms. We investigated 11 potential moderators of treatment effect (age, employment, suicidal ideation, marital status, financial difficulty, education, social support, family history of depression, life events, health and past antidepressant use). Using multiple linear regression, we investigated the appropriate interaction term for each of these potential moderators with treatment as allocated.

Results
Family history of depression was the only variable with weak evidence of effect modification (p-value for interaction=0.048), such that those with no family history of depression may have greater benefit from antidepressant treatment. We found no evidence of effect modification (p-value for interactions≥0.29) by any of the other ten variables.

Conclusion
Evidence for treatment moderators was extremely limited, supporting an approach of continuing discuss antidepressant treatment with all patients presenting with moderate to severe depressive symptoms.
Original languageEnglish
Article numbere0300366
Number of pages12
JournalPLoS ONE
Volume19
Issue number5
DOIs
Publication statusPublished - 9 May 2024

Bibliographical note

Publisher Copyright:
© 2024 Archer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Research Groups and Themes

  • Centre for Academic Primary Care

Fingerprint

Dive into the research topics of 'What predicts response to sertraline for people with depression in primary care? A secondary data analysis of moderators in the PANDA trial'. Together they form a unique fingerprint.

Cite this